Correlation of Inner Retinal Thickness Evaluated by Spectral-Domain Optical Coherence Tomography and Contrast Sensitivity in Parkinson disease

BACKGROUND:To compare inner retinal layer (IRL) thickness measured by spectral-domain optical coherence tomography (SD-OCT) and contrast sensitivity (CS) in patients with Parkinson disease (PD) and in healthy control (HC) subjects. METHODS:Consecutive patients with and without PD were prospectively...

Full description

Saved in:
Bibliographic Details
Published inJournal of neuro-ophthalmology Vol. 33; no. 2; pp. 137 - 142
Main Authors Adam, Christopher R., Shrier, Eric, Ding, Yin, Glazman, Sofya, Bodis-Wollner, Ivan
Format Journal Article
LanguageEnglish
Published United States Lippincott Williams & Wilkins, Inc 01.06.2013
Subjects
Online AccessGet full text
ISSN1070-8022
1536-5166
1536-5166
DOI10.1097/WNO.0b013e31828c4e1a

Cover

Loading…
Abstract BACKGROUND:To compare inner retinal layer (IRL) thickness measured by spectral-domain optical coherence tomography (SD-OCT) and contrast sensitivity (CS) in patients with Parkinson disease (PD) and in healthy control (HC) subjects. METHODS:Consecutive patients with and without PD were prospectively analyzed using SD-OCT and Pelli-Robson CS testing. SD-OCT IRL (ganglion-cell complex) thickness, consisting of the nerve fiber layer, ganglion cell layer, and inner plexiform layer, was segmented using an RTVue Model-RT100 with an EMM5 scan parameter covering a 5.0 × 5.0 mm cube centered on the fovea. Thickness voxel measurements at 0.25-mm intervals at sequential radial distances from the foveola were acquired horizontally and vertically. SD-OCT thickness raw data files were imported and analyzed within MATLAB (version 7.10.0). A database of CS scores and IRL thickness values by foveal location was constructed and statistically evaluated using JMP 10 (SAS Institute, Inc, Cary, NC). RESULTS:The results were compared between 28 eyes of 14 patients with PD and 28 eyes of 14 HC subjects. Controlling for age, mean CS scores of monocular right and randomized eyes were statistically lower in PD eyes (P < 0.05). IRL was significantly thinner in PD eyes than in HC eyes at several distances from the foveola (P < 0.05). The most numerous and significant thickness differences by diagnosis were located in the superior quadrant at a distance of 1.00–1.75 mm from the foveal center (17 μm; P < 0.01, maximum significant thickness difference and P value). Correlation was demonstrated between monocular CS and IRL thickness by diagnosis at multiple foveal locations for HC eyes as followsnasal quadrant, 0.75–1.00 mm (P < 0.02); temporal quadrant, 0.50–1.00 mm (P < 0.05); superior quadrant, 1.00 mm (P < 0.05); and inferior quadrant, 1.00 mm (P < 0.03). No significant correlation was found between monocular CS and IRL thickness within PD subjects (P > 0.05 for each foveal location measured). CONCLUSION:CS and foveal IRL thickness are decreased in patients with PD. CS and IRL thickness correlated in HC subjects; however, no such correlation was demonstrated in PD. The functional deficit of dopaminergic interneurons, including amacrine cells, may outstrip the anatomic structural changes in the inner retina of PD patients. Inner retinal atrophic changes may underlie the pathogenesis of CS deficit and IRL thinning in PD.
AbstractList To compare inner retinal layer (IRL) thickness measured by spectral-domain optical coherence tomography (SD-OCT) and contrast sensitivity (CS) in patients with Parkinson disease (PD) and in healthy control (HC) subjects.BACKGROUNDTo compare inner retinal layer (IRL) thickness measured by spectral-domain optical coherence tomography (SD-OCT) and contrast sensitivity (CS) in patients with Parkinson disease (PD) and in healthy control (HC) subjects.Consecutive patients with and without PD were prospectively analyzed using SD-OCT and Pelli-Robson CS testing. SD-OCT IRL (ganglion-cell complex) thickness, consisting of the nerve fiber layer, ganglion cell layer, and inner plexiform layer, was segmented using an RTVue Model-RT100 with an EMM5 scan parameter covering a 5.0 × 5.0 mm cube centered on the fovea. Thickness voxel measurements at 0.25-mm intervals at sequential radial distances from the foveola were acquired horizontally and vertically. SD-OCT thickness raw data files were imported and analyzed within MATLAB (version 7.10.0). A database of CS scores and IRL thickness values by foveal location was constructed and statistically evaluated using JMP 10 (SAS Institute, Inc, Cary, NC).METHODSConsecutive patients with and without PD were prospectively analyzed using SD-OCT and Pelli-Robson CS testing. SD-OCT IRL (ganglion-cell complex) thickness, consisting of the nerve fiber layer, ganglion cell layer, and inner plexiform layer, was segmented using an RTVue Model-RT100 with an EMM5 scan parameter covering a 5.0 × 5.0 mm cube centered on the fovea. Thickness voxel measurements at 0.25-mm intervals at sequential radial distances from the foveola were acquired horizontally and vertically. SD-OCT thickness raw data files were imported and analyzed within MATLAB (version 7.10.0). A database of CS scores and IRL thickness values by foveal location was constructed and statistically evaluated using JMP 10 (SAS Institute, Inc, Cary, NC).The results were compared between 28 eyes of 14 patients with PD and 28 eyes of 14 HC subjects. Controlling for age, mean CS scores of monocular right and randomized eyes were statistically lower in PD eyes (P < 0.05). IRL was significantly thinner in PD eyes than in HC eyes at several distances from the foveola (P < 0.05). The most numerous and significant thickness differences by diagnosis were located in the superior quadrant at a distance of 1.00-1.75 mm from the foveal center (17 μm; P < 0.01, maximum significant thickness difference and P value). Correlation was demonstrated between monocular CS and IRL thickness by diagnosis at multiple foveal locations for HC eyes as follows: nasal quadrant, 0.75-1.00 mm (P < 0.02); temporal quadrant, 0.50-1.00 mm (P < 0.05); superior quadrant, 1.00 mm (P < 0.05); and inferior quadrant, 1.00 mm (P < 0.03). No significant correlation was found between monocular CS and IRL thickness within PD subjects (P > 0.05 for each foveal location measured).RESULTSThe results were compared between 28 eyes of 14 patients with PD and 28 eyes of 14 HC subjects. Controlling for age, mean CS scores of monocular right and randomized eyes were statistically lower in PD eyes (P < 0.05). IRL was significantly thinner in PD eyes than in HC eyes at several distances from the foveola (P < 0.05). The most numerous and significant thickness differences by diagnosis were located in the superior quadrant at a distance of 1.00-1.75 mm from the foveal center (17 μm; P < 0.01, maximum significant thickness difference and P value). Correlation was demonstrated between monocular CS and IRL thickness by diagnosis at multiple foveal locations for HC eyes as follows: nasal quadrant, 0.75-1.00 mm (P < 0.02); temporal quadrant, 0.50-1.00 mm (P < 0.05); superior quadrant, 1.00 mm (P < 0.05); and inferior quadrant, 1.00 mm (P < 0.03). No significant correlation was found between monocular CS and IRL thickness within PD subjects (P > 0.05 for each foveal location measured).CS and foveal IRL thickness are decreased in patients with PD. CS and IRL thickness correlated in HC subjects; however, no such correlation was demonstrated in PD. The functional deficit of dopaminergic interneurons, including amacrine cells, may outstrip the anatomic structural changes in the inner retina of PD patients. Inner retinal atrophic changes may underlie the pathogenesis of CS deficit and IRL thinning in PD.CONCLUSIONCS and foveal IRL thickness are decreased in patients with PD. CS and IRL thickness correlated in HC subjects; however, no such correlation was demonstrated in PD. The functional deficit of dopaminergic interneurons, including amacrine cells, may outstrip the anatomic structural changes in the inner retina of PD patients. Inner retinal atrophic changes may underlie the pathogenesis of CS deficit and IRL thinning in PD.
To compare inner retinal layer (IRL) thickness measured by spectral-domain optical coherence tomography (SD-OCT) and contrast sensitivity (CS) in patients with Parkinson disease (PD) and in healthy control (HC) subjects. Consecutive patients with and without PD were prospectively analyzed using SD-OCT and Pelli-Robson CS testing. SD-OCT IRL (ganglion-cell complex) thickness, consisting of the nerve fiber layer, ganglion cell layer, and inner plexiform layer, was segmented using an RTVue Model-RT100 with an EMM5 scan parameter covering a 5.0 × 5.0 mm cube centered on the fovea. Thickness voxel measurements at 0.25-mm intervals at sequential radial distances from the foveola were acquired horizontally and vertically. SD-OCT thickness raw data files were imported and analyzed within MATLAB (version 7.10.0). A database of CS scores and IRL thickness values by foveal location was constructed and statistically evaluated using JMP 10 (SAS Institute, Inc, Cary, NC). The results were compared between 28 eyes of 14 patients with PD and 28 eyes of 14 HC subjects. Controlling for age, mean CS scores of monocular right and randomized eyes were statistically lower in PD eyes (P < 0.05). IRL was significantly thinner in PD eyes than in HC eyes at several distances from the foveola (P < 0.05). The most numerous and significant thickness differences by diagnosis were located in the superior quadrant at a distance of 1.00-1.75 mm from the foveal center (17 μm; P < 0.01, maximum significant thickness difference and P value). Correlation was demonstrated between monocular CS and IRL thickness by diagnosis at multiple foveal locations for HC eyes as follows: nasal quadrant, 0.75-1.00 mm (P < 0.02); temporal quadrant, 0.50-1.00 mm (P < 0.05); superior quadrant, 1.00 mm (P < 0.05); and inferior quadrant, 1.00 mm (P < 0.03). No significant correlation was found between monocular CS and IRL thickness within PD subjects (P > 0.05 for each foveal location measured). CS and foveal IRL thickness are decreased in patients with PD. CS and IRL thickness correlated in HC subjects; however, no such correlation was demonstrated in PD. The functional deficit of dopaminergic interneurons, including amacrine cells, may outstrip the anatomic structural changes in the inner retina of PD patients. Inner retinal atrophic changes may underlie the pathogenesis of CS deficit and IRL thinning in PD.
BACKGROUND:To compare inner retinal layer (IRL) thickness measured by spectral-domain optical coherence tomography (SD-OCT) and contrast sensitivity (CS) in patients with Parkinson disease (PD) and in healthy control (HC) subjects. METHODS:Consecutive patients with and without PD were prospectively analyzed using SD-OCT and Pelli-Robson CS testing. SD-OCT IRL (ganglion-cell complex) thickness, consisting of the nerve fiber layer, ganglion cell layer, and inner plexiform layer, was segmented using an RTVue Model-RT100 with an EMM5 scan parameter covering a 5.0 × 5.0 mm cube centered on the fovea. Thickness voxel measurements at 0.25-mm intervals at sequential radial distances from the foveola were acquired horizontally and vertically. SD-OCT thickness raw data files were imported and analyzed within MATLAB (version 7.10.0). A database of CS scores and IRL thickness values by foveal location was constructed and statistically evaluated using JMP 10 (SAS Institute, Inc, Cary, NC). RESULTS:The results were compared between 28 eyes of 14 patients with PD and 28 eyes of 14 HC subjects. Controlling for age, mean CS scores of monocular right and randomized eyes were statistically lower in PD eyes (P < 0.05). IRL was significantly thinner in PD eyes than in HC eyes at several distances from the foveola (P < 0.05). The most numerous and significant thickness differences by diagnosis were located in the superior quadrant at a distance of 1.00–1.75 mm from the foveal center (17 μm; P < 0.01, maximum significant thickness difference and P value). Correlation was demonstrated between monocular CS and IRL thickness by diagnosis at multiple foveal locations for HC eyes as followsnasal quadrant, 0.75–1.00 mm (P < 0.02); temporal quadrant, 0.50–1.00 mm (P < 0.05); superior quadrant, 1.00 mm (P < 0.05); and inferior quadrant, 1.00 mm (P < 0.03). No significant correlation was found between monocular CS and IRL thickness within PD subjects (P > 0.05 for each foveal location measured). CONCLUSION:CS and foveal IRL thickness are decreased in patients with PD. CS and IRL thickness correlated in HC subjects; however, no such correlation was demonstrated in PD. The functional deficit of dopaminergic interneurons, including amacrine cells, may outstrip the anatomic structural changes in the inner retina of PD patients. Inner retinal atrophic changes may underlie the pathogenesis of CS deficit and IRL thinning in PD.
Author Shrier, Eric
Ding, Yin
Bodis-Wollner, Ivan
Adam, Christopher R.
Glazman, Sofya
AuthorAffiliation Departments of Ophthalmology (ES) and Neurology (SG, IV-B), College of Medicine (CRA), SUNY-Downstate Medical Center, Brooklyn, New York; SUNY Eye Institute (ES, IV-B), Brooklyn, New York; and Department of Electrical Engineering (YD), Polytechnic Institute of NYU, Brooklyn, New York
AuthorAffiliation_xml – name: Departments of Ophthalmology (ES) and Neurology (SG, IV-B), College of Medicine (CRA), SUNY-Downstate Medical Center, Brooklyn, New York; SUNY Eye Institute (ES, IV-B), Brooklyn, New York; and Department of Electrical Engineering (YD), Polytechnic Institute of NYU, Brooklyn, New York
Author_xml – sequence: 1
  givenname: Christopher
  surname: Adam
  middlename: R.
  fullname: Adam, Christopher R.
  organization: Departments of Ophthalmology (ES) and Neurology (SG, IV-B), College of Medicine (CRA), SUNY-Downstate Medical Center, Brooklyn, New York; SUNY Eye Institute (ES, IV-B), Brooklyn, New York; and Department of Electrical Engineering (YD), Polytechnic Institute of NYU, Brooklyn, New York
– sequence: 2
  givenname: Eric
  surname: Shrier
  fullname: Shrier, Eric
– sequence: 3
  givenname: Yin
  surname: Ding
  fullname: Ding, Yin
– sequence: 4
  givenname: Sofya
  surname: Glazman
  fullname: Glazman, Sofya
– sequence: 5
  givenname: Ivan
  surname: Bodis-Wollner
  fullname: Bodis-Wollner, Ivan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23612240$$D View this record in MEDLINE/PubMed
BookMark eNqNkctuFDEQRS0URB7wBwh5yaaDX_1ih4YAkSIGkUEsLbe7TJtx243tTjQ_wTdjSLLJioVll3xulereU3TkgweEXlJyTknfvvn-eXtOBkI5cNqxTgug6gk6oTVvqpo2zVF5k5ZUHWHsGJ2m9JMQwgnrn6FjxhvKmCAn6PcmxAhOZRs8DgZfeg8Rf4VsvXJ4N1m995ASvrhRblUZRjwc8PUCOkflqvdhVtbj7ZKtLvgmTBDBa8C7MIcfUS3TASs_lg9f-JTxNfhks72x-YCL8IuKe-tTGT3aBCrBc_TUKJfgxf19hr59uNhtPlVX24-Xm3dXlRa06yveCaJMz6DuB2UYA9qNugXF2uJIZzShtaZa99rU1HSGibqvG0HVOLDigdD8DL2-67vE8GuFlOVskwbnlIewJkl5zYnglDQFfXWPrsMMo1yinVU8yAcPC_D2DtAxpBTBSG3zP0PLztZJSuTfwGQJTD4OrIjFI_FD__-T3QaXIaa9W28hygmUy5MsQQvKWVuxIiNNKatySM__AFeArJg
CitedBy_id crossref_primary_10_1186_s41983_021_00421_1
crossref_primary_10_1016_j_jns_2019_06_009
crossref_primary_10_1111_ene_15896
crossref_primary_10_3389_fncel_2017_00091
crossref_primary_10_1007_s10072_020_04289_6
crossref_primary_10_31083_j_jin2203056
crossref_primary_10_1371_journal_pone_0074439
crossref_primary_10_1007_s00702_020_02224_9
crossref_primary_10_1016_j_neubiorev_2016_01_002
crossref_primary_10_1002_mds_26533
crossref_primary_10_1186_s12920_021_01005_x
crossref_primary_10_1007_s00417_018_3957_1
crossref_primary_10_1007_s00401_018_01956_z
crossref_primary_10_1038_srep03921
crossref_primary_10_1212_WNL_0000000000006157
crossref_primary_10_1016_j_parkreldis_2024_107229
crossref_primary_10_1016_j_parkreldis_2016_10_006
crossref_primary_10_1097_ICU_0000000000000000
crossref_primary_10_1177_201010581402300112
crossref_primary_10_3389_fnins_2020_00921
crossref_primary_10_1097_WNO_0000000000000203
crossref_primary_10_1186_s40478_016_0346_z
crossref_primary_10_1136_bmjopen_2015_009658
crossref_primary_10_1007_s10792_021_02133_0
crossref_primary_10_3389_fnins_2021_726476
crossref_primary_10_1136_practneurol_2020_002824
crossref_primary_10_1016_j_parkreldis_2020_11_025
crossref_primary_10_1002_mds_27454
crossref_primary_10_1016_j_parkreldis_2015_09_015
crossref_primary_10_1016_j_parkreldis_2016_07_004
crossref_primary_10_1167_tvst_13_4_3
crossref_primary_10_1097_OPX_0000000000001650
crossref_primary_10_1002_mds_28182
crossref_primary_10_1038_nrneurol_2014_79
crossref_primary_10_1016_j_exer_2021_108693
crossref_primary_10_1016_j_preteyeres_2018_02_002
crossref_primary_10_1007_s10792_018_0934_y
crossref_primary_10_1093_texcom_tgab042
crossref_primary_10_1002_mds_27728
crossref_primary_10_3389_fnins_2020_567129
crossref_primary_10_3389_fneur_2017_00710
crossref_primary_10_1097_OPX_0000000000001449
crossref_primary_10_1016_j_ymgmr_2021_100767
crossref_primary_10_1002_mds_25741
crossref_primary_10_1007_s00702_014_1214_2
crossref_primary_10_1177_2040622319882205
crossref_primary_10_1007_s13760_020_01274_w
crossref_primary_10_1186_s12886_016_0216_2
crossref_primary_10_3389_fnins_2021_799526
crossref_primary_10_3389_fnagi_2022_832768
crossref_primary_10_1016_j_preteyeres_2020_100938
crossref_primary_10_1016_j_parkreldis_2015_08_002
crossref_primary_10_1371_journal_pone_0123229
crossref_primary_10_3389_fneur_2020_577362
crossref_primary_10_1002_mds_25896
crossref_primary_10_1167_jov_24_4_5
crossref_primary_10_5664_jcsm_8212
crossref_primary_10_1097_WNO_0000000000000505
crossref_primary_10_3389_fneur_2017_00701
crossref_primary_10_1364_JOSAA_382042
crossref_primary_10_1002_ana_25897
Cites_doi 10.1007/BF01946404
10.1007/s10633-007-9091-8
10.5301/EJO.2010.1318
10.1212/WNL.40.11.1710
10.1016/j.visres.2004.06.009
10.1212/01.wnl.0000280584.64363.83
10.1212/WNL.45.12.2143
10.1016/S0042-6989(00)00036-5
10.1007/BF01186992
10.1212/01.wnl.0000294876.49861.dc
10.1136/bjo.87.7.899
10.1016/S0022-510X(99)00204-X
10.1068/p170315
10.1111/j.1755-3768.1979.tb00517.x
10.1136/bjo.69.1.51
10.1001/archneur.1995.00540340109020
10.1002/mds.1099
10.1001/archopthalmol.2011.1576
10.1016/0168-5597(95)00169-7
10.1093/brain/110.2.415
10.1093/brain/111.1.131
10.1093/brain/110.6.1675
10.1002/1097-0185(20001001)260:2<124::AID-AR20>3.0.CO;2-D
10.1016/j.ophtha.2011.10.010
10.1001/archophthalmol.2009.106
10.1007/s00702-009-0292-z
10.1017/S0952523800002303
10.1136/bjo.2007.131094
10.1023/B:DOOP.0000019487.88486.0a
10.1155/2012/728457
10.1016/0166-2236(90)90113-O
10.1093/brain/101.4.661
10.1016/0042-6989(94)90248-8
10.1016/S0042-6989(97)00129-6
ContentType Journal Article
Copyright 2013 Lippincott Williams & Wilkins, Inc.
Copyright_xml – notice: 2013 Lippincott Williams & Wilkins, Inc.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1097/WNO.0b013e31828c4e1a
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1536-5166
EndPage 142
ExternalDocumentID 23612240
10_1097_WNO_0b013e31828c4e1a
00041327-201306000-00009
Genre Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.GJ
.Z2
0R~
2V-
53G
5GY
5RE
5VS
AAAAV
AAHPQ
AAIQE
AARTV
AASCR
AAYEP
ABASU
ABBUW
ABDIG
ABJNI
ABPXF
ABVCZ
ABXRP
ABXVJ
ABZAD
ABZZY
ACDDN
ACEWG
ACGFO
ACGFS
ACILI
ACNCT
ACWDW
ACWRI
ACXJB
ACXNZ
ADBBV
ADFPA
ADGGA
ADHPY
ADNKB
AE3
AE6
AEETU
AENEX
AFBFQ
AFDTB
AFUWQ
AHQNM
AHRYX
AHVBC
AINUH
AJCLO
AJIOK
AJNWD
AJNYG
AJZMW
AKCTQ
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
BAWUL
BQLVK
BS7
C45
CS3
DIK
DIWNM
DU5
DUNZO
E.X
E3Z
EBS
EEVPB
EJD
EX3
F2K
F2L
F5P
FCALG
FL-
GNXGY
GQDEL
H0~
HLJTE
HZ~
IKREB
IN~
IPNFZ
JK3
JK8
K8S
KD2
KMI
L-C
N~M
O9-
OCUKA
ODA
OK1
OL1
OLG
OLV
OLZ
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OXXIT
P-K
P2P
R58
RIG
RLZ
S4R
S4S
TEORI
TR2
TSPGW
V2I
W3M
WOQ
WOW
X3V
X3W
YFH
ZFV
ZZMQN
AAFWJ
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c4189-3840af92e59baf22e18dc7ea270b08fc015c1cc9cf51f8f24595641adb20034c3
ISSN 1070-8022
1536-5166
IngestDate Thu Jul 10 23:30:25 EDT 2025
Thu Apr 03 06:56:58 EDT 2025
Tue Jul 01 03:16:28 EDT 2025
Thu Apr 24 23:09:06 EDT 2025
Fri May 16 03:44:05 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4189-3840af92e59baf22e18dc7ea270b08fc015c1cc9cf51f8f24595641adb20034c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
PMID 23612240
PQID 1353043106
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_1353043106
pubmed_primary_23612240
crossref_citationtrail_10_1097_WNO_0b013e31828c4e1a
crossref_primary_10_1097_WNO_0b013e31828c4e1a
wolterskluwer_health_00041327-201306000-00009
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2013-June
2013-06-00
2013-Jun
20130601
PublicationDateYYYYMMDD 2013-06-01
PublicationDate_xml – month: 06
  year: 2013
  text: 2013-June
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of neuro-ophthalmology
PublicationTitleAlternate J Neuroophthalmol
PublicationYear 2013
Publisher Lippincott Williams & Wilkins, Inc
Publisher_xml – name: Lippincott Williams & Wilkins, Inc
References Bodis-Wollner (R22-9-20210126) 2011; 52
Ikeda (R16-9-20210126) 1994; 34
Witkovsky (R17-9-20210126) 2004; 108
de Rijk (R2-9-20210126) 1995; 45
Bodis-Wollner (R20-9-20210126) 1987; 110
Harnois (R15-9-20210126) 1990; 31
Ross (R28-9-20210126) 1985; 69
Leung (R33-9-20210126) 2012; 119
Djamgoz (R14-9-20210126) 1997; 37
Mestre (R6-9-20210126) 1990; 40
Trenkwalder (R3-9-20210126) 1995; 52
Bodis-Wollner (R7-9-20210126) 1978; 101
Schutte (R13-9-20210126) 1991; 20
Derefeldt (R26-9-20210126) 1979; 57
Reader (R40-9-20210126) 1986; 42
Bodis-Wollner (R38-9-20210126) 2011; 52
Shrier (R42-9-20210126) 2012; 2012
Knight (R29-9-20210126) 2012; 130
Regan (R41-9-20210126) 1987; 110
Valenti (R11-9-20210126) 2007; 69
Aaker (R36-9-20210126) 2010; 4
Altintas (R35-9-20210126) 2008; 1116
Crassini (R25-9-20210126) 1988; 17
Gao (R30-9-20210126) 1992; 33
Bodis-Wollner (R44-9-20210126) 2009; 116
Watson (R21-9-20210126) 1990; 4
La Morgia (R37-9-20210126) 2013; 20
Inzelberg (R34-9-20210126) 2004; 44
Moschos (R39-9-20210126) 2011; 21
Elliott (R27-9-20210126) 1987; 7
Harman (R31-9-20210126) 2000; 260
Bodis-Wollner (R43-9-20210126) 1990; 13
Tagliati (R8-9-20210126) 1996; 100
Ghilardi (R19-9-20210126) 1988; 111
Alamouti (R23-9-20210126) 2003; 87
Shulman (R4-9-20210126) 2001; 16
Rodnitzky (R5-9-20210126) 1998; 5
Pieri (R9-9-20210126) 2000; 172
Hajee (R10-9-20210126) 2009; 127
Pulicken (R12-9-20210126) 2007; 69
Eriksson (R24-9-20210126) 2009; 93
Jonas (R32-9-20210126) 1992; 33
Wink (R18-9-20210126) 2000; 40
References_xml – volume: 4
  start-page: 1427
  year: 2010
  ident: R36-9-20210126
  article-title: Detection of retinal changes in Parkinsons disease with spectral-domain optical coherence tomography.
  publication-title: Clin Ophthalmol
– volume: 33
  start-page: 1
  year: 1992
  ident: R30-9-20210126
  article-title: Aging of the human retina. Differential loss of neurons and retinal pigment epithelial cells.
  publication-title: Invest Ophthalmol Vis Sci
– volume: 42
  start-page: 1242
  year: 1986
  ident: R40-9-20210126
  article-title: Dopamine in the visual cortex of the cat.
  publication-title: Experientia
  doi: 10.1007/BF01946404
– volume: 1116
  start-page: 137
  year: 2008
  ident: R35-9-20210126
  article-title: Correlation between retinal morphological and functional findings and clinical severity in Parkinsons Disease.
  publication-title: Doc Ophthalmol
  doi: 10.1007/s10633-007-9091-8
– volume: 21
  start-page: 24
  year: 2011
  ident: R39-9-20210126
  article-title: Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss.
  publication-title: Eur J Ophthalmol
  doi: 10.5301/EJO.2010.1318
– volume: 40
  start-page: 1710
  year: 1990
  ident: R6-9-20210126
  article-title: Spatiotemporal contrast sensitivity differs in normal aging and Parkinsons disease.
  publication-title: Neurology
  doi: 10.1212/WNL.40.11.1710
– volume: 44
  start-page: 2793
  year: 2004
  ident: R34-9-20210126
  article-title: Retinal nerve fiber layer thinning in Parkinson disease.
  publication-title: Vision Res
  doi: 10.1016/j.visres.2004.06.009
– volume: 69
  start-page: 1060
  year: 2007
  ident: R11-9-20210126
  article-title: Neuroimaging of retinal nerve fiber layer in AD using optical coherence tomography.
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000280584.64363.83
– volume: 7
  start-page: 415
  year: 1987
  ident: R27-9-20210126
  article-title: Contrast sensitivity decline with ageing: a neural or optical phenomenon Ophthalmic Physiol Opt.
– volume: 45
  start-page: 2143
  year: 1995
  ident: R2-9-20210126
  article-title: Prevalence of Parkinsons disease in the elderly: the Rotterdam Study.
  publication-title: Neurology
  doi: 10.1212/WNL.45.12.2143
– volume: 31
  start-page: 2473
  year: 1990
  ident: R15-9-20210126
  article-title: Decreased dopamine in the retinas of patients with Parkinsons disease.
  publication-title: Invest Ophthalmol Vis Sci
– volume: 40
  start-page: 1937
  year: 2000
  ident: R18-9-20210126
  article-title: A model of the parkinsonian visual system: support for the dark adaptation hypothesis.
  publication-title: Vision Res
  doi: 10.1016/S0042-6989(00)00036-5
– volume: 20
  start-page: 195
  year: 1991
  ident: R13-9-20210126
  article-title: Dopaminergic interplexiform cells and centrifugal fibres in the Xenopus retina.
  publication-title: J Neurocytol
  doi: 10.1007/BF01186992
– volume: 33
  start-page: 2012
  year: 1992
  ident: R32-9-20210126
  article-title: Human optic nerve fiber count and optic disc size.
  publication-title: Invest Ophthalmol Vis Sci
– volume: 69
  start-page: 2085
  year: 2007
  ident: R12-9-20210126
  article-title: Optical coherence tomography and disease subtype in multiple sclerosis.
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000294876.49861.dc
– volume: 87
  start-page: 899
  year: 2003
  ident: R23-9-20210126
  article-title: Retinal thickness decreases with age: an OCT study.
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjo.87.7.899
– volume: 172
  start-page: 7
  year: 2000
  ident: R9-9-20210126
  article-title: Decreased color discrimination and contrast sensitivity in Parkinsons disease.
  publication-title: J Neurol Sci
  doi: 10.1016/S0022-510X(99)00204-X
– volume: 20
  start-page: 198
  year: 2013
  ident: R37-9-20210126
  article-title: Loss of temporal retinal nerve fibers in Parkinson disease: a mitochondrial pattern Eur J Neurol.
– volume: 17
  start-page: 315
  year: 1988
  ident: R25-9-20210126
  article-title: Age-related changes in contrast sensitivity in central and peripheral retina.
  publication-title: Perception
  doi: 10.1068/p170315
– volume: 57
  start-page: 679
  year: 1979
  ident: R26-9-20210126
  article-title: Age variations in normal human contrast sensitivity.
  publication-title: Acta Ophthalmol (Copenh)
  doi: 10.1111/j.1755-3768.1979.tb00517.x
– volume: 69
  start-page: 51
  year: 1985
  ident: R28-9-20210126
  article-title: Effect of age on contrast sensitivity function: uniocular and binocular findings.
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjo.69.1.51
– volume: 52
  start-page: 1017
  year: 1995
  ident: R3-9-20210126
  article-title: Starnberg trial on epidemiology of parkinsonism and hypertension in the elderly. Prevalence of Parkinsons disease and related disorders assessed by a door-to-door survey of inhabitants older than 65 years.
  publication-title: Arch Neurol
  doi: 10.1001/archneur.1995.00540340109020
– volume: 16
  start-page: 507
  year: 2001
  ident: R4-9-20210126
  article-title: Comorbidity of the nonmotor symptoms of Parkinsons disease.
  publication-title: Mov Disord
  doi: 10.1002/mds.1099
– volume: 130
  start-page: 312
  year: 2012
  ident: R29-9-20210126
  article-title: Effect of race, age, and axial length on optic nerve head parameters and retinal nerve fiber layer thickness measured by Cirrus HD-OCT.
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopthalmol.2011.1576
– volume: 100
  start-page: 1
  year: 1996
  ident: R8-9-20210126
  article-title: The pattern electroretinogram in Parkinsons disease reveals lack of retinal spatial tuning.
  publication-title: Electroencephalogr Clin Neurophysiol
  doi: 10.1016/0168-5597(95)00169-7
– volume: 110
  start-page: 415
  year: 1987
  ident: R41-9-20210126
  article-title: Orientation-selective visual loss in patients with Parkinsons disease.
  publication-title: Brain
  doi: 10.1093/brain/110.2.415
– volume: 111
  start-page: 131
  year: 1988
  ident: R19-9-20210126
  article-title: Spatial frequency dependent abnormalities of the pattern electroretinogram and visual evoked potentials in a parkinsonian monkey model.
  publication-title: Brain
  doi: 10.1093/brain/111.1.131
– volume: 52
  start-page: 6660
  year: 2011
  ident: R38-9-20210126
  article-title: Remodeling of the fovea in Parkinson disease.
  publication-title: Invest Ophthalmol Vis Sci
– volume: 110
  start-page: 1675
  year: 1987
  ident: R20-9-20210126
  article-title: Visual dysfunction in Parkinsons disease. Loss in spatiotemporal contrast sensitivity.
  publication-title: Brain
  doi: 10.1093/brain/110.6.1675
– volume: 260
  start-page: 124
  year: 2000
  ident: R31-9-20210126
  article-title: Neuronal density in the human retinal ganglion cell layer from 16-77 years.
  publication-title: Anat Rec
  doi: 10.1002/1097-0185(20001001)260:2<124::AID-AR20>3.0.CO;2-D
– volume: 119
  start-page: 731
  year: 2012
  ident: R33-9-20210126
  article-title: Retinal nerve fiber layer imaging with spectral-domain optical coherence tomography: a prospective analysis of age- related loss.
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2011.10.010
– volume: 127
  start-page: 737
  year: 2009
  ident: R10-9-20210126
  article-title: Inner retinal layer thinning in Parkinson disease.
  publication-title: Arch Ophthalmol
  doi: 10.1001/archophthalmol.2009.106
– volume: 116
  start-page: 1493
  year: 2009
  ident: R44-9-20210126
  article-title: Retinopathy in Parkinson disease.
  publication-title: J Neural Transm
  doi: 10.1007/s00702-009-0292-z
– volume: 52
  start-page: 6660
  year: 2011
  ident: R22-9-20210126
  article-title: Remodeling of the fovea in Parkinson disease.
  publication-title: Invest Ophthalmol Vis Sci
– volume: 4
  start-page: 147
  year: 1990
  ident: R21-9-20210126
  article-title: Gain, noise, and contrast sensitivity of linear visual neurons.
  publication-title: Vis Neurosci
  doi: 10.1017/S0952523800002303
– volume: 93
  start-page: 1448
  year: 2009
  ident: R24-9-20210126
  article-title: Macular thickness decreases with age in normal eyes: a study on the macular thickness map protocol in the Stratus OCT.
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjo.2007.131094
– volume: 108
  start-page: 17
  year: 2004
  ident: R17-9-20210126
  article-title: Dopamine and retinal function.
  publication-title: Doc Ophthalmol
  doi: 10.1023/B:DOOP.0000019487.88486.0a
– volume: 2012
  start-page: 728457
  year: 2012
  ident: R42-9-20210126
  article-title: Intraocular asymmetry of foveal thickness in Parkinson disease.
  publication-title: J Ophthalmol
  doi: 10.1155/2012/728457
– volume: 13
  start-page: 296
  year: 1990
  ident: R43-9-20210126
  article-title: Visual deficits related to dopamine deficiency in experimental animals and Parkinsons disease patients.
  publication-title: Trends Neurosci
  doi: 10.1016/0166-2236(90)90113-O
– volume: 101
  start-page: 661
  year: 1978
  ident: R7-9-20210126
  article-title: Measurements of visual evoked potentials in Parkinsons disease.
  publication-title: Brain
  doi: 10.1093/brain/101.4.661
– volume: 34
  start-page: 2629
  year: 1994
  ident: R16-9-20210126
  article-title: Electrophysiological signs of retinal dopamine deficiency in recently diagnosed Parkinsons disease and a follow up study.
  publication-title: Vision Res
  doi: 10.1016/0042-6989(94)90248-8
– volume: 5
  start-page: 102
  year: 1998
  ident: R5-9-20210126
  article-title: Visual dysfunction in Parkinsons disease.
  publication-title: Clin Neurosci
– volume: 37
  start-page: 3509
  year: 1997
  ident: R14-9-20210126
  article-title: Neurobiology of retinal dopamine in relation to degenerative states of the tissue.
  publication-title: Vision Res
  doi: 10.1016/S0042-6989(97)00129-6
SSID ssj0003029
Score 2.261372
Snippet BACKGROUND:To compare inner retinal layer (IRL) thickness measured by spectral-domain optical coherence tomography (SD-OCT) and contrast sensitivity (CS) in...
To compare inner retinal layer (IRL) thickness measured by spectral-domain optical coherence tomography (SD-OCT) and contrast sensitivity (CS) in patients with...
SourceID proquest
pubmed
crossref
wolterskluwer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 137
SubjectTerms Aged
Analysis of Variance
Contrast Sensitivity - physiology
Female
Functional Laterality
Humans
Male
Middle Aged
Parkinson Disease - complications
Parkinson Disease - diagnosis
Perceptual Disorders - diagnosis
Perceptual Disorders - etiology
Retina - pathology
Tomography, Optical Coherence
Title Correlation of Inner Retinal Thickness Evaluated by Spectral-Domain Optical Coherence Tomography and Contrast Sensitivity in Parkinson disease
URI https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00041327-201306000-00009
https://www.ncbi.nlm.nih.gov/pubmed/23612240
https://www.proquest.com/docview/1353043106
Volume 33
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbtQwELWWIiEQQtxZbjISb1UgcS6bPFblUkAtD7SiPEW24yirZjerblao_Qj-gH9lxrGdbLeIy0u0yia2lHMyHk9mzhDyEtbYRKo49jhTKWxQUuHxkGO0KRCwfIZJIrDeef8g2TuKPh7Hx6PRz0HW0qoVr-T5pXUl_4MqnANcsUr2H5B1g8IJ-A34whEQhuNfYbyLrTVq5_TpNlrbWJaoU8irqTzRhswoene-pi6tPOW1VzQzPoX7Fq0RCamM4mzbzIyOtSl6w_jvst1eYq67aTYBN2K9tC4dW_vIs-nnasVMr1lUbcXr2VoUf6fo6DhQOOgTGL9U2EzP2mrncJseLN-mjtXva35u47hNecaHgQzdVMIGMpQ1vokXB10XFmudO5kMw0I2MLVBJxazsQR00sJfDz73MV6WykgFfHg5ALmYaVqg-gz6Nf2C6NIU7V9XyFUGuxC0-28-fHILfeizzFZjZpPXl02JWtNmkHXHZ2M3c4Pc_N5ggsTyRNdHDLycw9vkloGN7nRcu0NGan6XXNs3CRj3yI8B5WhTUk05aihHHeWooxwVZ_QC5aihHHWUoz3lKFCOWsrRAeVgKuooRw3l7pOjd28Pd_c809LDk1GQZl6YRj4vM6biTPCSMRWkhZwozibw5NJSgnMqAykzWcZBmZYsimH_HgW8EJhEGcnwAdmaN3P1CHPy-CQUBZOocclFLDi4wjCKFDLLJFNjEtrnnUujd49tV-rc5l0AYPlFwMbEc3ctOr2XP1z_wkKZg2HGr218rprVMseGMqhc5Sdj8rDD2I1oOQGzrYGed8XPmBECziWbePie-IlRf_Czx78d6Qm53r9TT8lWe7pSz8BdbsVzTdpfPu3FVg
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Correlation+of+inner+retinal+thickness+evaluated+by+spectral-domain+optical+coherence+tomography+and+contrast+sensitivity+in+Parkinson+disease&rft.jtitle=Journal+of+neuro-ophthalmology&rft.au=Adam%2C+Christopher+R&rft.au=Shrier%2C+Eric&rft.au=Ding%2C+Yin&rft.au=Glazman%2C+Sofya&rft.date=2013-06-01&rft.eissn=1536-5166&rft.volume=33&rft.issue=2&rft.spage=137&rft_id=info:doi/10.1097%2FWNO.0b013e31828c4e1a&rft_id=info%3Apmid%2F23612240&rft.externalDocID=23612240
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1070-8022&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1070-8022&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1070-8022&client=summon